CHNA
Loncar China BioPharma ETFCHNA Fund Description
CHNA tracks a tier-weighted index of companies directly involved in the growth of China’s pharmaceutical and biotech industry.
CHNA Factset Analytics Insight
CHNA targets China’s pharmaceutical and biotech (biopharma) sector. The fund includes pharmaceutical companies, biotech companies, drug manufacturers, diagnostics companies, wholesalers or distributors of biopharma products, and biopharma service providers. It is worth noting that manufacturers of pharmaceutical ingredients are excluded, as the fund focuses on innovation in the sector. CHNA uses a tiered weighting system. Starting from equal weight, all qualified constituents are assigned a weight adjustment based on market cap. Large cap stocks get a 140% adjustment, midcaps 100%, and small-caps 70%. The index is reconstituted on every second Monday of each February and August.
CHNA Summary Data
CHNA Portfolio Data
CHNA Index Data
CHNA Portfolio Management
CHNA Tax Exposures
CHNA Fund Structure
CHNA Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of CHNA. CHNA is rated a 2 out of 5.
CHNA Tradability
CHNA Sector/Industry Breakdown
CHNA
CHNA Top 10 Holdings[View All]
CHNA Countries
CHNA
CHNA Regions
CHNA
CHNA Economic Development
CHNA
CHNA Performance Statistics
CHNA Benchmark Comparison Summary
CHNA
CHNA Benchmark Comparison Market Cap Size
CHNA